Huge, record-breaking haul for @VivekGRamaswamy.
Grassroots. Business leaders. Everyday Ohioans.
Vivek’s unifying vision for Ohio is resonating, and momentum continues to build.
Scoop: Ramaswamy raised over $8.5M in campaign for governor https://t.co/IAtlRInPVz
I was in the room last night. The fear I saw on people’s faces was real.
This person is part of the deranged left whom the media and Democrat Party take seriously. When she is immediately calling this assassination attempt “fake”, it tells you everything. Their rhetoric has poisoned the well to the point where reality doesn’t matter.
It’s dangerous. There’s no other way to put it.
The pictures tell the story. 📖
⬆️ Top pic: @VivekGRamaswamy tonight. Energy off the charts. 📈 Huge crowds everywhere. Campaign at max speed.
⬇️ Bottom pic: @amyactonoh a few days ago. Campaign in free fall after alcohol + pills + domestic incident = cops 🚓controversy boils over.🍸
Vote May 5! 🇺🇸🐘🇺🇸
“The fundraising report, shared first with Fox News Digital Tuesday, also highlights that Ramaswamy had $30 million in his campaign coffers at the end of last month. Separately, a Ramaswamy-aligned super PAC reported $29.5 million in fundraising so far this cycle, which, combined with the campaign, amounts to roughly $80 million brought in over the past year.”
Inbox: Vivek Ramaswamy's campaign announces it raised $9.88 million during the second half of 2025, and brought in nearly $20m total for the year.
"You simply don’t see this level of support in a gubernatorial race in Ohio," Campaign Manager Jonathan Ewing, said in a statement.
Here we go again. The truth is that Vivek achieved success by improving people’s lives. He led Roivant, one of the few biotech companies founded in the 21st century with currently a $10+ billion market cap. They developed life-saving & life-changing therapies, 5 of which are FDA approved (for diseases from congenital athymia to endometriosis to prostate cancer), and continue to develop more.
Roivant spun off multiple other companies. Immunovant, Myovant, and Urovant were very successful. One of them, Axovant, was not. It developed an Alzheimer’s drug. Many experts & top drug developers believed it deserved to be developed. So they did. But 99% of Alzheimer’s drugs have failed. So did theirs.
Neither Roivant nor Vivek never sold a share of Axovant before its failure. That’s a libelous lie. It would have been permissible, but in fact they didn’t.
(And the shares Vivek has sold in Roivant over the years are worth MUCH more today).
And btw, Vivek has also founded multiple other successful companies. Now go achieve success in life yourself, instead of slandering someone else’s. It’s lame & un-American.
Here’s a recent Forbes piece that lays out how Vivek built his wealth:
https://t.co/9haOKIP2gY
Mehdi Hassan absolutely cooked Vivek Ramaswamy.
Built his fortune hyping an Alzheimer’s drug that had already failed trials.
Talked it up on CNBC and Forbes. IPO’d.
Then the drug failed again.
Company lost 75% in a single day.
Teachers’ pensions and ordinary investors got wiped out.
Vivek? Cashed out $37 million beforehand.
Call it what it is: a pump-and-dump dressed up as “entrepreneurship.” .@mehdirhasan
I’m Vivek’s campaign manager & can confirm this never happened. Vivek was in Ohio yesterday and hasn’t been to D.C. in a while. Good luck groveling for clicks!
I’m Vivek’s campaign manager & can confirm this never happened. Vivek was in Ohio yesterday and hasn’t been to D.C. in a while. Good luck groveling for clicks!